22 /100
LOW RISK
Score updated Jul 13, 2026

TMCI — Treace Medical Concepts, Inc. Dilution Risk Tracker

Track TMCI dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track TMCI — Get alerts when the score changes →

As of July 13, 2026, Treace Medical Concepts, Inc. (TMCI) has a DilutionWatch DilutionScore of 22/100, rated LOW dilution risk. Treace Medical Concepts, Inc. has a market capitalization of $224.46M, 64.87M shares outstanding, 120 institutional holders tracked. Key dilution vectors include 713.3K outstanding warrants, approximately 48 months of cash runway.

Source: DilutionWatch (dilutionwatch.com) — data updated daily from SEC EDGAR filings. Not financial advice.

📊 Score Breakdown

📋 Offering Ability
40
💰 Cash Runway
0
📊 Float Risk
25
⚠️ Warrant Exposure
15
🔄Convertible Debt

🌦️ Dilution Forecast

Watch
Minor dilution signals detected
15%
🔄 Reverse Split 30%
• 50-day avg $1.97 approaching $1 threshold
🔔 Track TMCI — Get forecast alerts →

💹 Market Data

Market Cap$224.46M
Shares Outstanding64.87M
Float48.00M
Cash$51.85M
Debt$55.82M
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↑ 8.4% shares (2026Q1 vs prior)
120 institutional holders · 39.40M shares
#1 ARMISTICE CAPITAL, LLC 6.36M shares
#2 GAGNON SECURITIES LLC 5.20M shares
#3 BlackRock, Inc. 3.34M shares
+ 17 more holders Sign up free to view →

📉 Short Interest

Short Interest1.75M
Days to Cover1.0
% of Float3.6%
FINRA data as of Jun 30, 2026

📁 Recent SEC Activity

xbrl XBRL WARRANT Jul 07, 2026
4 INSIDER TRANSACTION Apr 03, 2026
4 INSIDER TRANSACTION Mar 11, 2026
4 INSIDER TRANSACTION Mar 11, 2026
4 INSIDER TRANSACTION Mar 11, 2026
Full SEC filing analysis available with free account

📰 Recent News

No recent news

📋 What This Means for TMCI Shareholders

Treace Medical Concepts, Inc. (TMCI) has a DilutionScore of 22/100, rated Low dilution risk. At this score level, DilutionWatch's real-time EDGAR monitoring shows limited near-term dilution signals. This does not mean zero dilution risk — shelf registrations can be filed and activated quickly — but the current filing profile shows no major outstanding dilution programs. Score as of July 13, 2026.

DilutionWatch tracks 713,330 outstanding warrants for TMCI. Warrants become dilutive when exercised — converting to common shares at the strike price. Warrants near or in-the-money deserve particular attention since exercise can add materially to the outstanding share count within a short window.

DilutionWatch tracks over 25 SEC filing types for TMCI in real-time, scanning EDGAR every 60 seconds. The DilutionWatch screener shows real-time score changes for TMCI alongside comparable low-risk stocks. Not financial advice — this analysis is for informational purposes only.

Warrants Explained →
Track TMCI Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking TMCI — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

🔗 Related Stocks — LOW Risk

Other LOW dilution risk stocks tracked by DilutionWatch with similar profiles:

Browse all 7,800+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
🔬 More Research for TMCI
📊 TMCI FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 TMCI Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.